(Total Views: 531)
Posted On: 10/18/2020 7:48:55 PM
Post# of 148932
“If the FDA actually requested the interim data, maybe Dr. Seethamraju's statement that the FDA is reviewing the unblinded data to the FDA as we speak is correct if the FDA requested it at the time of seeing the M2M CD10 results.”
Great detective work. Although I don’t always trust NP’s statements, his comment on Fox News combined with Dr. STJ’s comments on October 7tj align and I have no reason not to trust Dr. STJ. The question now is why would the FDA want to view the interim data? Are they considering approval based on the NEWS2 and S/C interim data? This scenario would also require unblinding of the data.
“Also, does anyone else find it peculiar that the last ProActive Investors interview was August 26, almost two months ago?”
And we should be thankful for Np stopping these videos. CYDY is a valued in the billions and should act as such. There are now over 43,000 share holders and uplisting is likely, Proactiv videos are for penny stocks, which were are not, and for CEOs who want to pump their stock, which No should no longer do.
Great detective work. Although I don’t always trust NP’s statements, his comment on Fox News combined with Dr. STJ’s comments on October 7tj align and I have no reason not to trust Dr. STJ. The question now is why would the FDA want to view the interim data? Are they considering approval based on the NEWS2 and S/C interim data? This scenario would also require unblinding of the data.
“Also, does anyone else find it peculiar that the last ProActive Investors interview was August 26, almost two months ago?”
And we should be thankful for Np stopping these videos. CYDY is a valued in the billions and should act as such. There are now over 43,000 share holders and uplisting is likely, Proactiv videos are for penny stocks, which were are not, and for CEOs who want to pump their stock, which No should no longer do.
(4)
(0)Scroll down for more posts ▼
